期刊文献+

埃索美拉唑对阿托伐他汀在犬体内的药动学影响

Effects of esomeprazole on pharmacokinetics of atorvastatin in dogs
原文传递
导出
摘要 目的:探讨埃索美拉唑对阿托伐他汀在犬体内的药动学影响。方法:Beagle犬8只,采用双周期双交叉试验将8只犬随机分为2组,每组4只,分别口服给药。一组单用阿托伐他汀,一组合用阿托伐他汀加埃索美拉唑,连续给药6d,采用HPLC法测定血浆中阿托伐他汀的浓度,比较2组的药动学参数。结果:两药合用时,阿托伐他汀的AUC(0-t)显著增大(P<0.05),其他药动学参数差异无显著性(P>0.05)。结论:埃索美拉唑能显著提高阿托伐他汀的生物利用度,但对其体内消除无显著影响。 OBJECTIVE To study the effects of esomeprazole on pharmacokinetics of atorvastatin in dogs. METHODS Eight Beagle dogs were randomly divided into two groups with dicycle and double cross test. One group was administrated with atorv astatin(5 mg.kg 1) for 6 days,and the other group was administrated with atorvastatin plus esomeprazole for 6 days. Plasma concentrations of atorvastatin in blood were measured by HPLC. The main pharmacokinetic parameters were calculated and compared by statistical analysis. RF_NULTS The pharmacokinetic parameters (AUC(0-t)) had statistical difference between two groups(P〈0. 05) ; The other pharmacokinetic parameters had no significant changes(P〉0.05). CONCLUSION Esomeprazole could apparently increase the bioavilibility of atorvastatin,while they almost had no effect on drug elimination process.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第8期614-616,共3页 Chinese Journal of Hospital Pharmacy
基金 宁夏自然科学基金(编号:NZ09126)
关键词 阿托伐他汀 埃索美拉唑 药动学 atorvastatin esomeprazole pharmacokinetics
  • 相关文献

参考文献3

二级参考文献51

  • 1楼雅卿,赵莉,张远.中国健康志愿者的奥美拉唑及其代谢物的药代动力学研究[J].中国临床药理学杂志,1994,10(1):14-21. 被引量:27
  • 2[1]Chong PH,Seeger JD,Franklin C.Clinically relevant differences between the statins:implications for therapeutic selection[J].Am Jmed,2001,111 (2):390-400.
  • 3[2]Fukazawa I,Uchida N,Uchida E,et al.Effect of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese[J].Br J Clin Pharmacol,2003,57 (4):448-455.
  • 4[3]Hermann M,Christensen H,Reubsaet JLE.Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS[J].Anal Bioanal Chem,2005,382 (10):1242-1249.
  • 5[4]Gibson DM,Stern RH,Abel RB,et al.Absolute bioavailability of atorvastatin in man[J].Pharm Res,1997,14(6):253.
  • 6[5]Bullen WW,Miller RA,Hayes RN.Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin,ortho-hydroxy atorvastatin,and para-hydroxy atorvastatin in human,dog,and rat plasma[J].J Am Soc Mass Spectrom,1999,10 (1):55-66.
  • 7[6]Hermann M,Christensen H,Reubsaet JLE.Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS[J].Anal Bioanal Chem,2005,382 (10):1242-1249.
  • 8[7]Borek-Dohalsk V,Huclová J,Barrett B,et al.Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma-pharmacokinetic study[J].Anal Bioanal Chem,2006,386 (2):275-285.
  • 9[8]Ramakrishna NVS,Koteshwara M,Vishwottam KN,et al.Simple,sensitive and rapid LC-MS-MS method for the quantitation of cerivastatin in human plasma-application to pharmacokine-tic studies[J].Pharma.& Biomedi Anal,2004,36(8):505-515.
  • 10Hassan A M,Andersson T,Niazi M,et al.A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers,S-Omeprazole (esomeprazole) and R-Omeprazole,in healthy subjects[J].Eur J Clin Pharmacol,2005,60(11):779-784.

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部